Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
- Author
- CUNHA, Rodrigo A1 ; FERRE, Sergi2 ; VAUGEOIS, Jean-Marie3 ; CHEN, Jiang-Fan4
[1] Center for Neuroscience of Coimbra, Institute of Biochemistry, Faculty of Medicine, University of Coimbra, Portugal
[2] National Institute on Drug Abuse, I.P.P., N.I.H., D.H.H.S, Baltimore, MD, United States
[3] Neuropsychopharmacology of Depression Unit, CNRS FRE 2735 (IFRMP), Institute for Biomedical Research, University of Rouen, France
[4] Department of Neurology, Boston University School of Medicine, United States - Issue title
- Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics
- Author (monograph)
- POPOLI, Patrizia (Editor)1
[1] Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy - Source
Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1512-1524, 13 p ; ref : 272 ref
- ISSN
- 1381-6128
- Scientific domain
- Pharmacology drugs
- Publisher
- Bentham Science, Hilversum
- Publication country
- Netherlands
- Document type
- Article
- Language
- English
- Author keyword
- A2A receptor ADHD Adenosine anxiety attention deficit hyperactivity disorder caffeine depression mood disorders psychiatric diseases schizophrenia
- Keyword (fr)
- Adénosine Angoisse anxiété Article synthèse Etat dépressif Mécanisme action Physiopathologie Récepteur adénosinique A2A Schizophrénie Traitement Trouble de l'humeur Trouble déficitaire de l'attention avec hyperactivité Trouble psychiatrique Affect affectivité Psychose
- Keyword (en)
- Adenosine Anxiety Review Depression Mechanism of action Pathophysiology A2A adenosine receptor Schizophrenia Treatment Mood disorder Attention disorder with hyperactivity Mental disorder Affect affectivity Psychosis
- Keyword (es)
- Adenosina Angustia ansiedad Artículo síntesis Estado depresivo Mecanismo acción Fisiopatología Receptor adenosínico A2A Esquizofrenia Tratamiento Trastorno humor Trastorno por déficit de atención e hiperactividad Trastorno psiquiátrico Afecto afectividad Psicosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B09 Neurotransmitters. Neurotransmission. Receptors / 002B02B09F Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C06 Psychoses / 002B18C06A Schizophrenia
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07A Depression
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18D Child clinical studies / 002B18D05 Attention deficit disorders. Hyperactivity
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03F Psychoses / 770-D03F01 Schizophrenia
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G01 Depression
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D04 Child clinical studies / 770-D04E Attention deficit disorders. Hyperactivity
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 20460487
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.2174/138161208784480090 
https://dx.doi.org/10.2174/138161208784480090
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.2174\/138161208784480090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Current pharmaceutical design\";s:9:\"\u0000*\u0000stitle\";s:16:\"Curr. pharm. des\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1512\";s:8:\"\u0000*\u0000epage\";s:4:\"1524\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1381-6128\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CUNHA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rodrigo A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"FERRE, Sergi\";i:1;s:20:\"VAUGEOIS, Jean-Marie\";i:2;s:15:\"CHEN, Jiang-Fan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:86:\"Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics\";s:8:\"\u0000*\u0000title\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:8:\"\u0000*\u0000place\";s:9:\"Hilversum\";s:6:\"\u0000*\u0000pub\";s:15:\"Bentham Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.2174\/138161208784480090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Current pharmaceutical design\";s:9:\"\u0000*\u0000stitle\";s:16:\"Curr. pharm. des\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1512\";s:8:\"\u0000*\u0000epage\";s:4:\"1524\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1381-6128\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CUNHA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rodrigo A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"FERRE, Sergi\";i:1;s:20:\"VAUGEOIS, Jean-Marie\";i:2;s:15:\"CHEN, Jiang-Fan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:86:\"Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics\";s:8:\"\u0000*\u0000title\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:8:\"\u0000*\u0000place\";s:9:\"Hilversum\";s:6:\"\u0000*\u0000pub\";s:15:\"Bentham Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.2174\/138161208784480090\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.2174\/138161208784480090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Current pharmaceutical design\";s:9:\"\u0000*\u0000stitle\";s:16:\"Curr. pharm. des\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1512\";s:8:\"\u0000*\u0000epage\";s:4:\"1524\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1381-6128\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CUNHA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rodrigo A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"FERRE, Sergi\";i:1;s:20:\"VAUGEOIS, Jean-Marie\";i:2;s:15:\"CHEN, Jiang-Fan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:86:\"Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics\";s:8:\"\u0000*\u0000title\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:8:\"\u0000*\u0000place\";s:9:\"Hilversum\";s:6:\"\u0000*\u0000pub\";s:15:\"Bentham Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.2174\/138161208784480090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Current pharmaceutical design\";s:9:\"\u0000*\u0000stitle\";s:16:\"Curr. pharm. des\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1512\";s:8:\"\u0000*\u0000epage\";s:4:\"1524\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1381-6128\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CUNHA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rodrigo A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"FERRE, Sergi\";i:1;s:20:\"VAUGEOIS, Jean-Marie\";i:2;s:15:\"CHEN, Jiang-Fan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:86:\"Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics\";s:8:\"\u0000*\u0000title\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:8:\"\u0000*\u0000place\";s:9:\"Hilversum\";s:6:\"\u0000*\u0000pub\";s:15:\"Bentham Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.2174\/138161208784480090\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Current pharmaceutical design\";s:9:\"\u0000*\u0000stitle\";s:16:\"Curr. pharm. des\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1512\";s:8:\"\u0000*\u0000epage\";s:4:\"1524\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1381-6128\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CUNHA\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rodrigo A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"FERRE, Sergi\";i:1;s:20:\"VAUGEOIS, Jean-Marie\";i:2;s:15:\"CHEN, Jiang-Fan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:86:\"Regulation of Brain Functions by Adenosine A2A Receptors: Implication for Therapeutics\";s:8:\"\u0000*\u0000title\";s:82:\"Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders\";s:8:\"\u0000*\u0000place\";s:9:\"Hilversum\";s:6:\"\u0000*\u0000pub\";s:15:\"Bentham Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
